National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007
作者： G. Caleb Alexander , Niraj L. Sehgal , Rachael M. Moloney , Randall S. Stafford
DOI: 10.1001/ARCHINTE.168.19.2088
关键词: Type 2 Diabetes Mellitus 、 Confidence interval 、 Sitagliptin 、 Endocrinology 、 Internal medicine 、 Type 2 diabetes 、 Medical prescription 、 Exenatide 、 Population 、 Diabetes mellitus 、 Medicine
摘要: … Significant shifts in diabetes treatment since 1994 are evident from our analysis of the IMS … patterns of diabetes treatment and pharmaceutical expenditures across treatment classes. …
stanford.edu
elsevier.com
sci-hub.se 参考文章(19)
Effects of intensive glucose lowering in type 2 diabetes The New England Journal of Medicine. ,vol. 358, pp. 2545- 2559 ,(2008) , 10.1056/NEJMOA0802743
Matthew C. Riddle, The underuse of insulin therapy in North America Diabetes-metabolism Research and Reviews. ,vol. 18, ,(2002) , 10.1002/DMRR.277
R. W. Grant, E. P. McCarthy, D. E. Singer, J. B. Meigs, Frequent outpatient contact and decreasing medication affordability in patients with diabetes from 1997 to 2004. Diabetes Care. ,vol. 29, pp. 1386- 1388 ,(2006) , 10.2337/DC06-0196
Jay S. Skyler, Carolyn Oddo, Diabetes trends in the USA. Diabetes-metabolism Research and Reviews. ,vol. 18, ,(2002) , 10.1002/DMRR.289
P. Valensi, E. Cosson, Is insulin detemir able to favor a lower variability in the action of injected insulin in diabetic subjects Diabetes & Metabolism. ,vol. 31, ,(2005) , 10.1016/S1262-3636(05)88265-5
R. W. Grant, Trends in Complexity of Diabetes Care in the United States From 1991 to 2000 Archives of Internal Medicine. ,vol. 164, pp. 1134- 1139 ,(2004) , 10.1001/ARCHINTE.164.10.1134
James P Boyle, Amanda A Honeycutt, KM Venkat Narayan, Thomas J Hoerger, Linda S Geiss, Hong Chen, Theodore J Thompson, None, Projection of Diabetes Burden Through 2050: Impact of changing demography and disease prevalence in the U.S. Diabetes Care. ,vol. 24, pp. 1936- 1940 ,(2001) , 10.2337/DIACARE.24.11.1936
Brian L. Strom, How the US Drug Safety System Should Be Changed JAMA. ,vol. 295, pp. 2072- 2075 ,(2006) , 10.1001/JAMA.295.17.2072
Bruce M. Psaty, David Korn, Congress Responds to the IOM Drug Safety Report—In Full JAMA. ,vol. 298, pp. 2185- 2187 ,(2007) , 10.1001/JAMA.298.18.2185
David S. H. Bell, Drugs for cardiovascular risk reduction in the diabetic patient. Current Diabetes Reports. ,vol. 1, pp. 133- 139 ,(2001) , 10.1007/S11892-001-0025-7